Showing 161–176 of 205 results
-
TEPEZZA (teprotumumab-trbw) for injection, for intravenous use Initial U.S. Approval: 2020
Read more -
TERLIVAZ (terlipressin) for injection
Read more -
TEZSPIRE (tezepelumab-ekko) injection
Read more -
TIBSOVO (ivosidenib tablets), for oral use. Initial U.S. Approval: 2018
Read more -
TIVDAK (tisotumab vedotin-tftv) for injection
Read more -
TIVICAY (dolutegravir) Tablets for Oral Use. Initial U.S. Approval: 2013
Read more -
TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use. Initial U.S. Approval: 2019
Read more -
TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use Initial U.S. Approval: 2014
Read more -
TRODELVY (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020
Read more -
TRUQAP (capivasertib) tablets
Read more -
TRUQAP (capivasertib) tablets
Read more -
TRUVADA (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004
Read more -
TUKYSA (tucatinib) tablets, for oral use Initial U.S. Approval: 2020
Read more -
TYSABRI (natalizumab) injection, for intravenous use. Initial U.S. Approval: 2004
Read more -
UNITUXIN (dinutuximab) injection, for intravenous use Initial U.S. Approval: 2015
Read more -
Valamor (Ribociclib) Tablets
Read more